Latin America’s cosmetic treatment landscape is experiencing a dramatic shift. Walk through any major medical district in cities such as São Paulo, Mexico ...
EDAP TMS SA announced the successful treatment of the first patient in its phase I/II PULS Trial, which is investigating the use of High Intensity Focused Ultrasound (HIFU) technology for pancreatic ...
One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...
Medical professionals have described the introduction of High-Intensity Focused Ultrasound (HIFU) technology for treating fibroids in Nigeria as a significant feat. The deployment of the technology by ...
Edap TMS SA recently published data showing that its Focal One high intensity focused ultrasound technology is non-inferior to radical prostatectomy as a first-line treatment for localized prostate ...
AUSTIN, Texas, March 27, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported today unaudited consolidated financial results for the fourth quarter and full ...
Semi-Live Focal One Procedure to be Conducted on August 15 t h at 5:00 pm (KST) LYON, France, August 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today ...
Medical professionals have described the introduction of High-Intensity Focused Ultrasound (HIFU) technology for treating fibroids in Nigeria as a significant feat. The deployment of the technology by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results